$BCLI
Brainstorm Cell Therapeutics Inc

2012 Q2 Form 10-Q Financial Statement

#000114420412028107 Filed on May 11, 2012

View on sec.gov

Income Statement

Concept 2012 Q2
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $450.0K
YoY Change -29.69%
% of Gross Profit
Research & Development $385.0K
YoY Change -34.75%
% of Gross Profit
Depreciation & Amortization $40.00K
YoY Change 0.0%
% of Gross Profit
Operating Expenses $833.0K
YoY Change -31.72%
Operating Profit -$829.0K
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change -100.0%
Pretax Income -$830.0K
YoY Change -23.85%
Income Tax $1.000K
% Of Pretax Income
Net Earnings -$830.0K
YoY Change -24.55%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$97.19K
COMMON SHARES
Basic Shares Outstanding 128.6M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $840.0K
YoY Change -71.03%
Cash & Equivalents $843.0K
Short-Term Investments
Other Short-Term Assets $140.0K
YoY Change 180.0%
Inventory
Prepaid Expenses
Receivables $420.0K
Other Receivables $0.00
Total Short-Term Assets $1.400M
YoY Change -55.27%
LONG-TERM ASSETS
Property, Plant & Equipment $300.0K
YoY Change -21.05%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $20.00K
YoY Change 100.0%
Other Assets $130.0K
YoY Change 44.44%
Total Long-Term Assets $450.0K
YoY Change -8.16%
TOTAL ASSETS
Total Short-Term Assets $1.400M
Total Long-Term Assets $450.0K
Total Assets $1.850M
YoY Change -48.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $520.0K
YoY Change 73.33%
Accrued Expenses $790.0K
YoY Change 31.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.450M
YoY Change 13.28%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $150.0K
YoY Change 66.67%
Total Long-Term Liabilities $150.0K
YoY Change 66.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.450M
Total Long-Term Liabilities $150.0K
Total Liabilities $1.600M
YoY Change 16.79%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $250.0K
YoY Change
Total Liabilities & Shareholders Equity $1.850M
YoY Change -48.9%

Cashflow Statement

Concept 2012 Q2
OPERATING ACTIVITIES
Net Income -$830.0K
YoY Change -24.55%
Depreciation, Depletion And Amortization $40.00K
YoY Change 0.0%
Cash From Operating Activities -$419.0K
YoY Change -47.63%
INVESTING ACTIVITIES
Capital Expenditures $9.000K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$9.000K
YoY Change -10.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $126.0K
YoY Change 152.0%
NET CHANGE
Cash From Operating Activities -$419.0K
Cash From Investing Activities -$9.000K
Cash From Financing Activities $126.0K
Net Change In Cash -$302.0K
YoY Change -60.26%
FREE CASH FLOW
Cash From Operating Activities -$419.0K
Capital Expenditures $9.000K
Free Cash Flow -$428.0K
YoY Change -46.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
798000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
1471000 USD
bcli Erosion Of Restricted Cash
ErosionOfRestrictedCash
6000 USD
bcli Expenses Related To Shares And Options Granted To Service Providers
ExpensesRelatedToSharesAndOptionsGrantedToServiceProviders
21490000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
6998000 USD
bcli Increase In Accounts Receivable And Prepaid Expenses
IncreaseInAccountsReceivableAndPrepaidExpenses
630000 USD
CY2012Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
128586644 shares
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1145000 USD
CY2000Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
24788000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17513000 USD
us-gaap Operating Expenses
OperatingExpenses
42301000 USD
us-gaap Interest Expense
InterestExpense
-2536000 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
-132000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
44705000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-81000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
44786000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
164000 USD
us-gaap Net Income Loss
NetIncomeLoss
-44950000 USD
CY2012Q1 bcli Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
0 USD
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
1039000 USD
us-gaap Severance Costs
SeveranceCosts
13000 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
451000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1864000 USD
us-gaap Increase Decrease In Fair Value Of Unhedged Derivative Instruments
IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments
795000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-12093000 USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-23000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12116000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1185000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-6000 USD
bcli Investment In Lease Deposit
InvestmentInLeaseDeposit
-17000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1196000 USD
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-16000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1212000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
12319000 USD
us-gaap Proceeds From Issuance Of Long Term Debt And Capital Securities Net
ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet
2061000 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
651000 USD
us-gaap Repayments Of Other Short Term Debt
RepaymentsOfOtherShortTermDebt
601000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
14430000 USD
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
43000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14473000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1145000 USD

Files In Submission

Name View Source Status
0001144204-12-028107-index-headers.html Edgar Link pending
0001144204-12-028107-index.html Edgar Link pending
0001144204-12-028107.txt Edgar Link pending
0001144204-12-028107-xbrl.zip Edgar Link pending
bcli-20120331.xml Edgar Link completed
bcli-20120331.xsd Edgar Link pending
bcli-20120331_cal.xml Edgar Link unprocessable
bcli-20120331_def.xml Edgar Link unprocessable
bcli-20120331_lab.xml Edgar Link unprocessable
bcli-20120331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v311796_10q.htm Edgar Link pending
v311796_ex10-1.htm Edgar Link pending
v311796_ex31-1.htm Edgar Link pending
v311796_ex31-2.htm Edgar Link pending
v311796_ex32-1.htm Edgar Link pending
v311796_ex32-2.htm Edgar Link pending